Company: RNAC
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001453687-25-000060
Chunk: 32

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 15
Chunk 32
---
 thereunder———Filed herewith10.4#Cartesian Therapeutics, Inc. 2016 Stock Incentive Plan, and forms of award agreements thereunderS-8333-27648699.11/12/202410.5#Non-Employee Director Compensation Program———Filed herewith10.6#Form of Indemnification Agreement for Directors and OfficersS-1333-21155510.55/24/201610.7†Amended and Restated License Agreement, dated as of May 31, 2017, by and between the Registrant and Shenyang Sunshine Pharmaceutical Co., Ltd.10-Q001-3779810.68/11/201710.8†Manufacturing Services Agreement, dated as of August 1, 2014, by and between the Registrant and Shenyang Sunshine Pharmaceutical Co., Ltd.S-1333-21155510.105/24/201610.9(a)Lease Agreement by and between BRE-BMR Grove LLC and Selecta Biosciences, Inc. dated July 23, 201910-Q001-3779810.311/8/201910.9(b)First Amendment to Lease by and between BRE-BMR Grove LLC and Selecta Biosciences, Inc. dated September 1, 202210-Q001-3779810.111/3/202210.10(a)†Lease Agreement by and between 704 Quince Orchard Owner, LLC and Cartesian Therapeutics, Inc. dated May 11, 201810-K001-3779810.11(a)3/7/202410.10(b)†First Amendment to Lease Agreement by and between 704 Quince Orchard Owner, LLC and Cartesian Therapeutics, Inc. dated March 22, 202110-K001-3779810.11(b)3/7/202410.10(c)†Second Amendment to Lease Agreement by and between 704 Quince Orchard Owner, LLC and Cartesian Therapeutics, Inc. dated May 3, 202110-K001-3779810.11(c)3/7/202410.11(a)†Lease Agreement by and between 7495 RP, LLC and Cartesian Therapeutics, Inc. dated February 28, 202410-K001-3779810.123/7/202410.11(b)†First Amendment to Lease Agreement by and between 7495 RP, LLC and the Registrant dated May 7,